Analysis

Guardant Health, Inc. (GH) Stock Analysis

Guardant Health, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to GH.

websiteGH/analysis/GH

Guardant Health, Inc.

Guardant Health, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to GH.

Stock profile

Ticker

GH

Asset type

Stock

Market cap

$17.47B

Sector

Health Technology

Industry

Medical Specialties

Currency

USD

Ticker listings

Guardant Health, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • GH primary listing
  • 5GH
  • A2N5RY
  • 1GH

Latest Guardant Health, Inc. news

Guardant Health Announces FDA Approval of Guardant360 CDx as Companion Diagnostic for Boehringer Ingelheim’s HERNEXEOS®

Guardant Health Announces FDA Approval of Guardant360 CDx as Companion Diagnostic for Boehringer Ingelheim’s

Gamehaus Holdings Inc. Announces Unaudited Financial Results for the Third Quarter of Fiscal 2026 Ended March 31, 2026

Gamehaus Holdings Inc. Announces Unaudited Financial Results for the Third Quarter of Fiscal 2026 Ended March 31,

Guardant Health and Collaborators to Present 38 Abstracts Highlighting Breadth and Expanded Clinical Utility of Guardant Liquid Biopsy Te...

PALO ALTO, Calif., May 28, 2026--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research collaborators will presen...

American Cancer Society Recommends Guardant Health’s Shield Blood Test in Updated Colorectal Cancer Screening Guidelines

American Cancer Society Recommends Guardant Health’s Shield Blood Test in Updated Colorectal Cancer Screening

FDA Approves New Guardant360 Liquid CDx, the Largest FDA-Approved Liquid Biopsy Panel with a 100x Expanded Footprint

FDA Approves New Guardant360 Liquid CDx, the Largest FDA-Approved Liquid Biopsy Panel with a 100x Expanded

Research sections

Valuation

Review valuation context for Guardant Health, Inc..

Future growth

Review future growth context for Guardant Health, Inc..

Past performance

Review past performance context for Guardant Health, Inc..

Financial health

Review financial health context for Guardant Health, Inc..

Dividend

Review dividend context for Guardant Health, Inc..

Management

Review management context for Guardant Health, Inc..

Ownership

Review ownership context for Guardant Health, Inc..

Other information

Review other information context for Guardant Health, Inc..

Community

Review community context for Guardant Health, Inc..